{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:37:54Z","timestamp":1780321074163,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.psyneuen.2016.11.006","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:19:15Z","timestamp":1478564355000},"page":"14-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Copeptin \u2013 A potential endocrine surrogate marker of CCK-4-induced panic symptoms?"],"prefix":"10.1016","volume":"76","author":[{"given":"C\u00fcneyt","family":"Demiralay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agorastos","family":"Agorastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Yassouridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2016.11.006_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0893-133X(00)00182-2","article-title":"Dose response of arginine vasopressin to the CCK-B agonist pentagastrin","volume":"24","author":"Abelson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/ajp.151.2.261","article-title":"Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients","volume":"151","author":"Bradwejn","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000126514","article-title":"Effects of cholecystokinin octapeptide on the hypothalamic-pituitary-adrenal axis function and on vasopressin, prolactin and growth hormone release in humans","volume":"58","author":"Calogero","year":"1993","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrendo.2015.224","article-title":"Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis","volume":"12","author":"Christ-Crain","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/15622975.2011.604351","article-title":"Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone","volume":"13","author":"Demiralay","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1781(87)90002-3","article-title":"Measurement of lactate-induced panic and anxiety","volume":"20","author":"Dillon","year":"1987","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euroneuro.2009.01.011","article-title":"Research in anxiety disorders: from the bench to the bedside","volume":"6","author":"Garner","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jcem-66-4-668","article-title":"Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man","volume":"66","author":"Hensen","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/cen.12608","article-title":"Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress","volume":"82","author":"Kacheva","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0050","first-page":"341","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level","volume":"29","author":"Katan","year":"2008","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.31887\/DCNS.2011.13.4\/mkellner","article-title":"Experimental panic provocation in healthy man-a translational role in anti-panic drug development?","volume":"13","author":"Kellner","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0060","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0196-9781(01)00462-4","article-title":"Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptide","volume":"22","author":"Le Melledo","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-68-4-837","article-title":"Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans","volume":"68","author":"Miaskiewicz","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 20","key":"10.1016\/j.psyneuen.2016.11.006_bib0070","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/EJE-14-0405","article-title":"Copeptin concentrations during psychological stress: the PsyCo study","volume":"171","author":"Siegenthaler","year":"2014","journal-title":"Eur. J. Endocrinol.\/Eur. Fed. Endocr. Soc."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.psyneuen.2015.10.009","article-title":"Association of HPA axis hormones with copeptin after psychological stress differs by sex","volume":"63","author":"Spanakis","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0085","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jpsychires.2009.02.004","article-title":"The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects","volume":"43","author":"Stroehle","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/10253890.2014.993966","article-title":"Copeptin as a stress marker prior and after a written examination \u2013 the CoEXAM study","volume":"18","author":"Urwyler","year":"2015","journal-title":"Stress (Amsterdam, Netherlands)"},{"key":"10.1016\/j.psyneuen.2016.11.006_bib0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0924-977X(96)00038-7","article-title":"Cholecystokinin in anxiety European neuropsychopharmac","volume":"6","author":"van Megen","year":"1996","journal-title":"J. Eur. Coll. Neuropsychopharmacol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016308915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016308915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:53:58Z","timestamp":1759683238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453016308915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":19,"alternative-id":["S0306453016308915"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.11.006","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copeptin \u2013 A potential endocrine surrogate marker of CCK-4-induced panic symptoms?","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}